By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

enGene, Inc. 

7171 Frederick-Banting

Montreal  Quebec  H4S 1Z9  Canada
Phone: 514.332.4888 Fax: n/a


SEARCH JOBS

enGene Inc., based in Montréal, QC, has developed a highly flexible nucleotide (DNA and RNAi) delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels. Our platform technology has the ability to significantly impact diseases of mucosal tissues such as the gastrointestinal tract, lung and bladder as well as provide systemic release of proteins from the gut to treat diabetes, anemia, hemophilia and others.

YEAR FOUNDED:

1999

LEADERSHIP:

CEO: Anthony Cheung

CMO: Theresa Podrebarac

CTO: Victor Knopov

CFO: Michele Jemus

JOBS:

Please click here for enGene job opportunities.

FOLLOW AMGEN:



Key Statistics


Email: info@engeneinc.com
Ownership: Private

Web Site: enGene
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
Industry Veteran Mr. Steve Gannon Joins enGene's Board of Directors 7/10/2017 8:12:52 AM
enGene Announces Appointment Of Theresa Podrebarac, MD, As Chief Medical Officer 5/1/2017 7:00:10 AM
enGene, Inc.'s Mucosal Gene Delivery Platform Is Successful In Targeting PD-L1 Expression In The Gut, Demonstrating Effective Treatment Of Colitis And Gvhd In Preclinical Models 4/28/2017 8:28:58 AM
Takeda (TKPYY) And enGene, Inc. Establish Strategic Alliance To Develop Novel Therapeutics For Gastrointestinal Diseases 1/12/2016 12:13:47 PM
enGene, Inc. Annouces The Appointment Of Dr. Dennis H. Langer To The Company's Board Of Directors 12/8/2015 12:22:31 PM
enGene, Inc., Johnson & Johnson (JNJ) Ink Inflammatory Bowel Disease Pact for C $441 Million 10/14/2015 6:54:53 AM
Forbion Capital Partners Leads CAD 13.5 Million (EUR 9.6 Million) Series B Financing Round For enGene, Inc. 1/26/2015 9:43:13 AM
Lumira Capital Announces Investment in enGene, Inc. 8/5/2013 6:46:52 AM
enGene, Inc. CSO to Present Key Pre-Clinical Data on EG-10 for Treating Inflammatory Bowel Disease 12/6/2010 11:28:13 AM
enGene, Inc. Adds Leading Nanomedicine Expert To Scientific Advisory Board 9/2/2010 9:44:10 AM
123
//-->